Replies to post #1214 on Enanta Pharmaceuticals Inc (ENTA)

[NY1972]

Is NVS the only pharma that put a cyclophilin inhibitor thru clinical trials? Merck, J&J and Gilead seem to be fixated on NS5B inhibitor?

[DewDiligence]

Transcript* of ENTA’s FY4Q15 CC:

http://finance.yahoo.com/news/edited-transcript-enta-earnings-conference-065602553.html

*Includes some errors.

[DewDiligence]

FDA accepts NDA for qD formulation of V-Pak: #msg-118870098.